Matches in SemOpenAlex for { <https://semopenalex.org/work/W2260883399> ?p ?o ?g. }
- W2260883399 endingPage "53" @default.
- W2260883399 startingPage "47" @default.
- W2260883399 abstract "Background Methadone and buprenorphine have been demonstrated to be effective in the treatment of opioid use disorder (OUD), especially when combined with psychosocial treatment. Despite buprenorphine's association with fewer withdrawal symptoms and lessened risk of abuse, compared with methadone, its adoption remains limited. Given the vital role that counselors may play in its successful implementation, their knowledge and perceptions of opioid agonist therapy may be facilitators or barriers to its acceptance. Methods Informed by diffusion theory, the current study examined perceptions of buprenorphine's and methadone's acceptability among 725 counselors employed in a nationally representative sample of substance use disorder treatment centers. First, we provided descriptive statistics about medication diffusion, extent of training received about the medications, and perceptions of acceptability of each medication. Then, we compared acceptability of opioid agonists with other treatment approaches for OUD. Finally, we conducted 2 ordinary least squares regressions to examine counselor acceptability of buprenorphine and of methadone. Results Descriptive statistics suggested that diffusion of information about buprenorphine and methadone was not complete, and training was not extensive for either medication. Counselors reported greater acceptability and training of buprenorphine compared with methadone. Methadone was rated as the least acceptable among all other treatment approaches. Multivariate analyses indicated regional differences, and that medication-specific training, adaptability, and educational attainment were positively related with perceptions of acceptability of either medication, even after controlling for organizational characteristics. Adherence to a 12-step orientation was negatively associated with acceptability. Conclusions Dissemination of information about opioid agonist therapy is occurring. Nevertheless, the fact that 20% of counselors admitted not knowing enough about either buprenorphine's or methadone's effectiveness is surprising in light of the extensive literature documenting their effectiveness. Future research should focus upon different types of training that can inform physicians, counselors, and patients about the use of opioid agonist therapy." @default.
- W2260883399 created "2016-06-24" @default.
- W2260883399 creator A5024455838 @default.
- W2260883399 creator A5050599495 @default.
- W2260883399 creator A5064168003 @default.
- W2260883399 creator A5076259158 @default.
- W2260883399 creator A5085578813 @default.
- W2260883399 date "2016-01-01" @default.
- W2260883399 modified "2023-10-16" @default.
- W2260883399 title "Counselor Training and Attitudes toward Pharmacotherapies for Opioid Use Disorder" @default.
- W2260883399 cites W1506471596 @default.
- W2260883399 cites W1607437209 @default.
- W2260883399 cites W1927111086 @default.
- W2260883399 cites W1974435062 @default.
- W2260883399 cites W1977049235 @default.
- W2260883399 cites W1978228420 @default.
- W2260883399 cites W1979517098 @default.
- W2260883399 cites W1992606538 @default.
- W2260883399 cites W1996743557 @default.
- W2260883399 cites W2002358708 @default.
- W2260883399 cites W2009779177 @default.
- W2260883399 cites W2014523709 @default.
- W2260883399 cites W2020155291 @default.
- W2260883399 cites W2048376222 @default.
- W2260883399 cites W2048645743 @default.
- W2260883399 cites W2059145916 @default.
- W2260883399 cites W2059240796 @default.
- W2260883399 cites W2061007797 @default.
- W2260883399 cites W2071305983 @default.
- W2260883399 cites W2076550582 @default.
- W2260883399 cites W2083511613 @default.
- W2260883399 cites W2103937850 @default.
- W2260883399 cites W2106405930 @default.
- W2260883399 cites W2108791771 @default.
- W2260883399 cites W2108795964 @default.
- W2260883399 cites W2116181377 @default.
- W2260883399 cites W2118101708 @default.
- W2260883399 cites W2118988525 @default.
- W2260883399 cites W2119653958 @default.
- W2260883399 cites W2121179640 @default.
- W2260883399 cites W2138706729 @default.
- W2260883399 cites W2143251012 @default.
- W2260883399 cites W2143467718 @default.
- W2260883399 cites W2145139215 @default.
- W2260883399 cites W2147528480 @default.
- W2260883399 cites W2150623781 @default.
- W2260883399 cites W2156508334 @default.
- W2260883399 cites W2164256639 @default.
- W2260883399 cites W2329096587 @default.
- W2260883399 cites W4248857718 @default.
- W2260883399 doi "https://doi.org/10.1080/08897077.2015.1062457" @default.
- W2260883399 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4879956" @default.
- W2260883399 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26168816" @default.
- W2260883399 hasPublicationYear "2016" @default.
- W2260883399 type Work @default.
- W2260883399 sameAs 2260883399 @default.
- W2260883399 citedByCount "32" @default.
- W2260883399 countsByYear W22608833992016 @default.
- W2260883399 countsByYear W22608833992017 @default.
- W2260883399 countsByYear W22608833992018 @default.
- W2260883399 countsByYear W22608833992019 @default.
- W2260883399 countsByYear W22608833992020 @default.
- W2260883399 countsByYear W22608833992021 @default.
- W2260883399 countsByYear W22608833992022 @default.
- W2260883399 countsByYear W22608833992023 @default.
- W2260883399 crossrefType "journal-article" @default.
- W2260883399 hasAuthorship W2260883399A5024455838 @default.
- W2260883399 hasAuthorship W2260883399A5050599495 @default.
- W2260883399 hasAuthorship W2260883399A5064168003 @default.
- W2260883399 hasAuthorship W2260883399A5076259158 @default.
- W2260883399 hasAuthorship W2260883399A5085578813 @default.
- W2260883399 hasBestOaLocation W22608833992 @default.
- W2260883399 hasConcept C118552586 @default.
- W2260883399 hasConcept C126322002 @default.
- W2260883399 hasConcept C150966472 @default.
- W2260883399 hasConcept C15744967 @default.
- W2260883399 hasConcept C170493617 @default.
- W2260883399 hasConcept C2778767360 @default.
- W2260883399 hasConcept C2778949969 @default.
- W2260883399 hasConcept C2779418921 @default.
- W2260883399 hasConcept C2781063702 @default.
- W2260883399 hasConcept C40010229 @default.
- W2260883399 hasConcept C70410870 @default.
- W2260883399 hasConcept C71924100 @default.
- W2260883399 hasConceptScore W2260883399C118552586 @default.
- W2260883399 hasConceptScore W2260883399C126322002 @default.
- W2260883399 hasConceptScore W2260883399C150966472 @default.
- W2260883399 hasConceptScore W2260883399C15744967 @default.
- W2260883399 hasConceptScore W2260883399C170493617 @default.
- W2260883399 hasConceptScore W2260883399C2778767360 @default.
- W2260883399 hasConceptScore W2260883399C2778949969 @default.
- W2260883399 hasConceptScore W2260883399C2779418921 @default.
- W2260883399 hasConceptScore W2260883399C2781063702 @default.
- W2260883399 hasConceptScore W2260883399C40010229 @default.
- W2260883399 hasConceptScore W2260883399C70410870 @default.
- W2260883399 hasConceptScore W2260883399C71924100 @default.
- W2260883399 hasIssue "1" @default.
- W2260883399 hasLocation W22608833991 @default.